DEF: Inception Growth Seeks Extension Amid Delisting & Liquidity Woes

Inception Growth Acquisition Limited seeks stockholder approval to extend its business combination deadline to February 2026, facing delisting and liquidity challenges.

Summary

• Stockholders are invited to a Special Meeting on October 9, 2025, to vote on extending the business combination deadline.
• The company proposes to amend its Charter and Trust Agreement to extend the deadline from October 13, 2025, to February 13, 2026, allowing for four additional one-month extensions.
• Each one-month extension requires a deposit of $0.075 per unredeemed Public Share into the Trust Account, funded by a non-interest bearing loan from the Sponsor.
• The company was delisted from Nasdaq on December 17, 2024, for failing to complete a business combination within 36 months of its IPO, and its securities now trade on the OTC Markets.
• As of September 12, 2025, the Trust Account held approximately $2,196,062.62, with a redemption price per Public Share of approximately $12.43.
• The closing price of Public Shares on the OTC Markets on September 12, 2025, was $11.50.
• If the extensions are approved and fully utilized, the projected redemption price could increase to approximately $12.73 per share by February 13, 2026, assuming no further redemptions.
• The Board of Directors recommends voting FOR all proposals: the Charter Amendment, the Trust Amendment, and the Adjournment Proposal.

Sentiment

Score: 3

Explanation: The sentiment is low due to the company's delisting from Nasdaq, persistent failure to complete a business combination, and the need for multiple extensions. While the sponsor's commitment to fund extensions offers a glimmer of hope, the significant risks associated with trading on the OTC market and the potential for warrants/rights to expire worthless weigh heavily on the outlook.

Positives

• The Sponsor, Soul Venture Partners LLC, intends to provide non-interest bearing loans to fund the extension payments, demonstrating a commitment to finding a business combination.
• The proposed extension provides additional time for the company to identify and complete an initial business combination, potentially preserving shareholder value over immediate liquidation.
• Public stockholders retain redemption rights, allowing them to exit their investment at a price higher than the current OTC market price.

Negatives

• The company failed to complete an initial business combination within the Nasdaq-mandated 36-month timeframe, leading to its delisting from Nasdaq on December 17, 2024.
• Securities now trade on the OTC Markets, which typically offers significantly reduced liquidity compared to Nasdaq.
• The market price of Public Shares ($11.50) is currently lower than the redemption price ($12.43), indicating market skepticism and potential losses for those selling on the open market.
• Repeated extensions and the associated costs (even if funded by the Sponsor as a loan) indicate ongoing difficulty in securing a suitable business combination.
• Warrants and rights will expire worthless if a business combination is not consummated, representing a complete loss for holders of these securities.

Risks

• Limited liquidity in the OTC Markets may prevent stockholders from selling their Public Shares, even if the market price is lower than the redemption price.
• Delisting from Nasdaq could lead to a determination that Public Shares are a 'penny stock,' resulting in more stringent trading rules for brokers and reduced trading activity.
• Delisting means securities are no longer 'covered securities' under the National Securities Markets Improvement Act of 1996, subjecting the company to state-level regulation for securities offerings, which could complicate and increase the cost of completing a business combination.
• Foreign ownership (Sponsor controlled by a Hong Kong national) may subject a potential U.S. target company business combination to review by the Committee on Foreign Investment in the United States (CFIUS), potentially delaying or prohibiting the transaction.
• The company faces a risk of being deemed an unregistered investment company under the Investment Company Act of 1940 if funds remain in U.S. government securities or money market funds for too long, which would force liquidation.
• If a business combination is not completed by the extended deadline, the company will be required to liquidate, and warrants and rights will expire worthless.

Future Outlook

The company intends to extend its deadline to complete a business combination to February 13, 2026, through four additional one-month extensions, contingent on stockholder approval. The Sponsor has indicated its willingness to fund these extensions via non-interest bearing loans. The company expects its securities to continue trading on the OTC Markets.

Management Comments

• "We believe that such redemption right enables its holders of Public Shares to determine whether to keep their investments for an additional period of time if the Company does not complete a business combination on or before the Current Termination Date."
• "After consultation with Soul Venture Partners LLC (the Sponsor), the Company’s management team has reasons to believe that, if the Charter Amendment and the Trust Amendment proposals are approved, the Sponsor or its affiliates or designees will, in connection with each one-month extension, contribute an aggregate amount equal to $0.075 multiplied by the number of Public Shares issued in the IPO (each, a Public Share) that has not been redeemed by the public stockholders, to the Company as a loan..."

Industry Context

This filing highlights the increasing challenges faced by Special Purpose Acquisition Companies (SPACs) in the current market environment, particularly those struggling to identify and complete business combinations within initial timelines. The delisting from Nasdaq due to failure to meet listing requirements underscores the heightened regulatory scrutiny and stricter enforcement of SPAC rules, such as Nasdaq IM-5101-2. The repeated need for extensions and the shift to OTC Markets reflect a broader trend of SPACs facing difficulties in a more competitive and less forgiving market, often leading to reduced investor confidence and liquidity issues. The mention of CFIUS review risk is also pertinent, as foreign-controlled SPACs increasingly encounter national security concerns when targeting U.S. businesses, adding another layer of complexity to the de-SPAC process.

Comparison to Industry Standards

• The company's failure to complete a business combination within 36 months of its IPO and subsequent delisting from Nasdaq deviates significantly from the industry standard for successful SPACs, which typically complete their mergers within the initial or first extended timeframe while maintaining major exchange listings.
• The repeated requests for extensions, now totaling multiple instances beyond the initial 15-21 month period, are indicative of substantial challenges in identifying and executing a viable business combination, contrasting with more efficient SPACs that finalize deals with fewer extensions.
• Trading on the OTC Markets rather than a major exchange like Nasdaq or NYSE places the company below industry benchmarks for liquidity, visibility, and institutional investor access, which are critical for post-merger growth and valuation.

Corporate Governance

Related Party Transactions

• Soul Venture Partners LLC (the Sponsor) or its affiliates/designees will provide non-interest bearing loans to the company to fund the monthly extension payments of $0.075 per unredeemed Public Share. These loans are repayable upon a business combination or forgiven if no business combination occurs (except for funds outside the Trust Account).

Stakeholder Impact

• Shareholders: Face continued uncertainty regarding a business combination, reduced liquidity on OTC Markets, and the risk of warrants/rights expiring worthless. However, they retain the option to redeem shares at a price higher than the current market value.
• Sponsor (Soul Venture Partners LLC): Will incur costs by providing loans for extensions, which are at risk of being forgiven if no business combination is completed, but gains more time to secure a deal and potentially realize value from its founder shares.
• Management: Gains additional time to execute a business combination, but operates under increased pressure and scrutiny due to delisting and repeated extensions.

Next Steps

• Stockholders will vote on the Charter Amendment, Trust Amendment, and Adjournment Proposals at the Special Meeting on October 9, 2025.
• Stockholders wishing to redeem their Public Shares must submit a written request and deliver their shares by October 7, 2025.
• If proposals are approved, the company will proceed with monthly extension payments to extend the business combination deadline up to February 13, 2026.
• The company will continue efforts to identify and consummate an initial business combination.

Key Dates

Recommendation

Given the company's delisting from Nasdaq, the significant liquidity challenges on the OTC Markets, and the repeated need for extensions to complete a business combination, the stock carries substantial risk. While the redemption price of $12.43 (or potentially $12.73 with full extensions) is currently higher than the market price of $11.50, the ability to sell on the open market is uncertain due to low liquidity. For public shareholders, the most prudent action is to exercise their redemption rights by October 7, 2025, to realize the higher redemption value and mitigate further exposure to the company's ongoing uncertainties and risks, including the potential for warrants and rights to expire worthless. Therefore, the recommendation is to 'sell' by redeeming shares.

Keywords

SPAC, Extension, Delisting, Proxy Statement, Business Combination, Trust Account, Redemption, OTC Markets, Corporate Governance, CFIUS, Investment Company Act, Shareholder Vote